All the content of the library is provided from Mayo Clinic in English.
As a member of the Mayo Clinic Care Network, RSPP has special access to Mayo Clinic knowledge and resources.
Pineoblastoma is a type of cancer that starts in the brain's pineal gland. The pineal gland is located in the center of the brain. The gland produces a hormone called melatonin. Melatonin plays a role in the body's natural sleep-wake cycle.
Pineoblastoma begins as a growth of cells in the pineal gland. The cells grow quickly and can invade and destroy healthy body tissue.
Pineoblastoma can occur at any age. But it happens most often in young children. Pineoblastoma may cause headaches, sleepiness and changes in the way the eyes move.
Pineoblastoma can be very difficult to treat. It can spread within the brain and into the fluid around the brain. This fluid is called cerebrospinal fluid. Pineoblastoma almost never spreads beyond the central nervous system. Treatment usually involves surgery to remove as much of the cancer as possible. Additional treatments also may be recommended.
Tests and procedures used to diagnose pineoblastoma include:
Imaging tests. Imaging tests can find the location and size of the brain tumor. Magnetic resonance imaging (MRI) is often used to diagnose brain tumors. Advanced techniques also may be used. These could include perfusion MRI and magnetic resonance spectroscopy.
Additional tests might include computerized tomography (CT) and positron emission tomography (PET) scans.
Pineoblastoma treatment options include:
Radiation therapy. Radiation therapy uses high-energy beams to kill cancer cells. These beams can come from X-rays, protons or other sources. During radiation therapy, a machine directs beams to the brain and spinal cord. Extra radiation is directed at the cancer cells.
Radiation is often given to the entire brain and spinal cord. This is because the cancer cells can spread from the brain to other parts of the central nervous system. This treatment is often recommended for adults and children older than 3.